Remifemin

Remifemin

Manufacturer:

Merck

Distributor:

BSV Bioscience Phils
Full Prescribing Info
Contents
Cimicifuga racemosa L. (black cohosh root and rhizome).
Description
Each tablet contains 0.018-0.026 ml Cimicifuga rhizome extract equivalent to 20 mg herbal substance.
Extraction solvent is isopropanol 40% (V/V).
Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] is a pharmaceutical produced from the medicinal plant Cimicifuga racemosa (black cohosh). By means of a standardized production procedure with constant monitoring of the contents of active compounds (triterpene glycosides) a consistent pharmaceutical quality is warranted.
Excipients/Inactive Ingredients: cellulose powder, lactose monohydrate, potato starch, magnesium stearate, peppermint oil.
Indications/Uses
Symptomatic treatment of menopausal complaints: Vasomotor symptoms such as hot flushes, sweating.
Psychovegetative symptoms such as sleep disorders, nervousness and depressive moods.
Neurovegetative complaints prior to menstrual bleeding (premenstrual) and in case of painful menstrual bleeding (dysmenorrhea).
Dosage/Direction for Use
Unless otherwise prescribed, take 1 tablet unchewed twice a day, one in the morning and one in the evening, with some liquid. Do not suck the tablet.
Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] does not reveal its action immediately. Initial therapeutic effects can be seen after six to eight weeks of treatment. As the results of treatment even improve further on prolonged administration, Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] should be given over a longer period but not longer than 6 months without medical advice.
Missed Dose: Do not take a double dose to make up for a forgotten tablet. If the patient has any further questions on the use of the medicinal product, ask a doctor or pharmacist.
Overdosage
In the event of overdose of Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)], the listed side effects may worsen.
When the patient has taken more than the recommended dosage: If this happens, the patient should stop taking the medicine and consult a doctor.
Contraindications
Do not take Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] if hypersensitive (allergic) to Cimicifuga rhizome (Black Cohosh rootstock) or any of the other ingredients of Remifemin. This medicine should not be used during pregnancy and lactation.
Special Precautions
Patients with a history of liver disease should take Cimicifuga preparations with caution.
Stop taking this product if signs and symptoms suggestive of liver injury develop such as tiredness, loss of appetite, yellowing of the skin and eyes or severe upper stomach pain with nausea and vomiting or dark urine. Consult a doctor immediately.
If vaginal bleeding occurs or other symptoms occur, a doctor should be consulted.
Estrogen may only be taken concurrently under medical supervision because Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] may intensify the effects of the estrogens. Consult a doctor. If the patient has been treated or if undergoing treatment for breast cancer or other hormone-dependent tumors, the patient should not use Cimicifuga preparations without medical advice.
If symptoms, which have led the patient to start the therapy with Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)], persist or worsen during the use of the medicinal product, a doctor or pharmacist should be consulted.
This medicine contains lactose. Therefore do not take Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] until the patient has consulted a doctor if he/she knows that he/she suffers from a sugar intolerance. Patients using herbal medicinal products should tell their doctor about it.
Consult a doctor: At the first sign of any adverse drug reaction, patient must seek medical attention immediately.
Use In Pregnancy & Lactation
Contraindicated during pregnancy & lactation.
Adverse Reactions
Rarely, allergic skin reactions (urticaria, itching skin, skin rash), facial edema and peripheral edema, gastrointestinal disorders (dyspepsia, diarrhea) and weight gain can occur after the use of Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)].
Cases of liver toxicity (including hepatitis, jaundice, disturbances in the liver function tests) have been reported with the use of Cimicifuga containing products. The frequency is not known.
In such cases, the patient should discontinue the product and contact a doctor.
If the patient observes side effects that are not described in this monograph please inform the doctor.
Drug Interactions
Interactions of Cimicifuga (black cohosh) rhizome extract with other medicines are not known.
Tell the doctor or pharmacist if the patient is taking, has recently taken or might take any other medicines.
Remifemin [Cimicifuga racemosa (Black cohosh root & rhizome)] with food and drink.
It is not known that food and drink would influence the mode of action of Remifemin.
Storage
Store at temperature not exceeding 25°C.
ATC Classification
G03CX - Other estrogens ; Used in estrogenic hormone preparations.
Presentation/Packing
Tab (round, slightly biconvex, whitish-beige colour) 60's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in